Skip to main content
SpringerLink
Log in

Treatment of Male Osteoporosis: Recent Advances with Alendronate

  • Review Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Medical Clinic 4, Klinikum Leverkusen, University of Cologne, Leverkusen, Germany, DE

    J. D. Ringe

  2. Oregon Health Science University, Portland, Oregon,, US

    E. Orwoll

  3. Merck Research Laboratories, Rahway, New Jersey, USA, US

    A. Daifotis & A. Lombardi

Authors
  1. J. D. Ringe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Orwoll
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Daifotis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Lombardi
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: 25 June 2001 / Accepted: 20 September 2001

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ringe, J., Orwoll, E., Daifotis, A. et al. Treatment of Male Osteoporosis: Recent Advances with Alendronate. Osteoporos Int 13, 195–199 (2002). https://doi.org/10.1007/s001980200013

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001980200013

Search

Navigation